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I am pleased to be selected as the 20th Annual Bishop 
Lecturer, joining a distinguished listof prior lecturers. It is 
noteworthy that both the Framingham Study and the Amer- 
ican College of Cardiology began operation 40 years ago. 
Both have grown in influence and stature, each cant 
to the explosive xpansion ofknowledge about cardi 
lar disease. 
It is fair to claim that he Framingham Study has p 
significant information over four decades that has helped 
researchers, scientists and physicians increase their under- 
standing of the factors predisposing tocardiovascular dis- 
ease. These have come to be known as “risk factors,” a 
term coined by the Framingham Study (1). Identification of
these modifiable risk factors helped stimulate the current 
interest in preventive cardiology all over the world. The 
increased awareness of cardiovascular risk factors provided 
by the Framingham Study research reports encouraged 
public health campaigns against moking in the 196Os, hyper- 
tension in the 1970s and against cholesterol inthe 1980s (2). 
In the decades of the 1930s through the 195Os, there was 
a mounting epidemic of cardiovascular mortality, such that 
cardiovascular disease became the leading cause of death in 
1949, accounting for 50% of all deaths. Although this fact 
was greeted with skepticism atthe time by some, the United 
States Public Health Service decided to explore the problem 
by seeking out modifiable predisposing factors (3). It was 
decided to use an epidemiologic approach that at the time 
was a novel idea. This entailed a long-term, observational 
prospective study, designed to learn in what particulars 
those who develop cardiovascular disease differ from those 
who escape it. In short, it was designed to learn which host 
and environmental f ctors predispose to cardiovascular dis- 
ease. 
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appraisal of the evolution and clinical rna~~~estat~~~s of 
coronary heart disease, including sudden death and silent 
disease. It rapidly became apparent that coronary disease is 
an extremely common and highly lethal disease. One in 
subjects developed a coronary attack before reaching age 
Women lagged behind men in incidence of myocardial 
infarction by 20 years. The disease could be.asym~tomat~c in 
its most severe form, about a third of myocardial nfarctions 
going unrecognized (4). The study demonstrated that almost 
one in every five coronary attacks presents with sudden 
death as the first, last and only symptom (5). Most deatbs 
occurred outside the hospital because half of coronary 
deaths occurred suddenly without warning. Appraisal of this 
“natural history” suggested that awaiting symptoms was a 
form of brinksmanship that could no longer be condoned. A 
coronary attack, it would appear, should be regarded as a 
medical failure rather than the first imdication for treatment. 
Hence, a preventive approach seemed essential. Fortu- 
nately, epidemiologic investigation of a number of moditi- 
able suspected predisposing factors indicated that coronary 
candidates can be identified for preventive management long 
in advance of symptoms. 
At the initiation of the Framingham Study, it was held 
that a single etiology for atherosclerotic disease would be 
found to be essential, and in most instances ufficient, o 
produce the pathology. However, three d cades of epidemi- 
oIogic research ave indicated that atherosclerotic cardio- 
vascular disease is distinctly multifactorial, This has given 
rise to the risk factor concept. The formuilation f causation 
is that certain life styles promote atherogenic traits in 
genetically susceptible persons; after prolonged exposure, 
these result in a compromised coronary circulation and, 
finally, clinical events. Thus, it is now generally acknowl- 
edged that atherosclerotic cardiovascular disease is a multi- 
factorial problem involving a variety of predisposing risk 
factors, each of which must be considered an ingredient ofa 
cardiovascular risk profile (6,7). 
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Figure 4. Four year risk of coronary heart disease according to 
ratio of cholesterol (C) lipoprotein fractions in men aged 50 to 79 
years. av. = average; other abbreviations as in Figure 2. 
HDL cholesterol ratio be used to estimate the combined 
effect of LDL and HDL cholesterol (Fig. 4). 
B pressure. Framingham Study investigations of the 
influence of blood pressure uncovered a number ofmiscon- 
ceptions. It was widely held that women and the elderly 
tolerated higher pressures well, and normal pressures for the 
elderly were designated at higher values than those for 
young adults. Investigations (IO) carried out indicated that 
by the criteria of the absolute risk, relative risk, risk gradi- 
ents and attributable risks, there was nothing to suggest that 
the elderly fared any better than younger persons at a given 
degree of hypertension. Also, by all criteria except absolute 
risk, women were no better off than men. 
At the time of the study, there was  prevalent concept, o 
some degree still held today, that the diastolic component of
blood pressure ischiefly responsible for the cardiovascular 
sequelae ofhypertension (I I). Prospective analysis revealed 
no closer linkage of cardiovascular outcomes tothe diastolic 
pressure, and even isolated elevation of systolic pressure 
was shown to carry ahigh risk (Fig. 5). The notion that only 
a fixed, “basal” blood pressure elevation was important was 
Piire 5. Risk of myocardial infarction with isolated systolic hy- 
pertension (3160/<95 mm Hg) in men aged 45 to 84 (Framingham 
Study, 24 year follow-up). Adj. = adjusted. Statistically significant 
(p < 0.01). Reprinted with permission from Kannel WB. J Cardio- 
vast Pharmacol 1989;13(suppl):S4-IO. 
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Figure 6. Risk of coronary heart disease in men aged 50 years by 
cardiovascular risk systolic pressure level. 
INTOL = glucose i rance; other abbreviations a  in 
(Framingbam Study, 26 year follow-up). 
also proved wrong (12). It is not safe to use the lowest 
pressure recorded on a patient o determine the nee 
treatment; it is the average eries of pressures that 
determines the risk. As for lipids, the ~~fl~e~ce of 
pressure on risk of cardiovascular disease was foun 
ing on coexistent risk factors (10) (Fig. 4). 
Impaired glucose tolerance, however 
determined, was also documented asan 
utor to cardiovascular disease (13). The 
be greater in women, in whom it elimi 
over men in vulnerability ocardiovascular disease. The risk 
associated with diabetes, like that for lipids and blood 
pressure, was also found to 
cardiovascular risk factors ( 
some unique independent i  
by the generally greater burden of risk factors, possibly 
en thrombogenesis. 
gen. Confirming findings in Northwick 
Gothenberg, the Framingham Study demonstrated that 
within the usual range of values, fibrinogen was another 
major independent atherogenic risk factor (Fig. 8). This 
factor may be involved in both atherogenesis and thrombo- 
genesis by effects on rheology of blood flow, viscosity of 
blood, distortability of red blood cells, plateiet aggregation 
and fibrin deposition. 
Figure 7. Risk of coronary heart disease in diabetic women accord- 
ing to level of other risk factors (Framingham Study, 26 year 
follow-up). CHOL. = cholesterol; GIG. = cigarette; IXP. = 
definite; other abbreviations as in Figure 3. 
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increased risk of overt clinical events (16). This very likely 
indicates a compromised coronary circulation with ischemic 
myocardial involvement. Electrocardiographic evidence of 
left ventricular hypertrophy, impaired intraventricular con- 
duction and nonspecific repolarization abnormalities, when 
otherwise unexplained, were all associated with an increased 
risk of coronary heart disease events. 
Left ventricular hype y on ECG. When the Framing- 
ham Study began, left ular hypertrophy on ECG was 
often considered an incidental finding in the course of hyper- 
tension, compensating for the elevated pressure load. HOW- 
ever, it soon became clear that this abnormality was n
ominous harbinger of lethal sequelae (17). It predisposed to all 
clinical manifestations of coronary heart disease including 
myocardial infarction, angina pectoris and sudden death tak- 
ing the level of blood pressure into account, when repolariza- 
tion abnormality was present along with increased voltage. 
Recent data using echocardiographic measurement of l ft 
ventricular mass indicate that risk is proportional to the 
degree of left ventricular hypertrophy with no critical value 
discernible. An exercise ECG provides till earlier evidence 
of a compromised coronary circulation i persons with a poor 
cardiovascular risk pr despite lack of symptoms. 
Silent myuwrdii tion. The appearance of ECG 
evidence of myocardial infarction provides unequivocal ev- 
idence of ischemic myocardial damage. The Framingham 
Study showed that many such heart attacks go unnoticed (4). 
About a third of men and women who sustained a myocar- 
dial infarction were not aware that they had suffered aheart 
attack. These silent or unrecognized heart attacks were 
detected by means of routine biennial ECG examinations. 
They were found to be especially frequent in diabetic men 
and in both men and women with hypertension (4). Despite 
tie benign appearance of these attacks, the outlook was 
found to be just as serious as for overt symptomatic attacks 
(4). Prospective studies of ambulatory ECG monitoring now 
being carried out should reveal still earlier evidence of silent 
ischemia foretelling clinical events oon to come in persons 
with an atherogenic r sk profile. 
The widely variable serum cholesterol values in this 
population almost universally exposed to an overload of fat 
and cholesterol strongly suggests a genetic influence. Some 
persons appear to be metabolic marvels. Such innate resist- 
ance and susceptibility was confirmed by demonstrating that 
a family history of premature cardiovascular disease confers 
risk among siblings (18). Also, a family history of hyperten- 
sion, diabetes and hyperlipidemia is significant. A positive 
family history may be permissive rather than determinative, 
requgng ex$nsure to modifiable risk factors to promote the 
occurrence of disease. Undergoing the menopause was 
found to escalate coronary heart disease risk threefold in 
women and to result in a more severe pattern of the disease. 
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lem involving lipid deposition, 
forces, carbohydrate tolerance and thrombogenesis, 
others. The risk associated with each of the major ris 
factors identified is markedly affected by the coexiste 
intensity of the others. Optimal risk predictions require a 
quantitative synthesis of risk factors into a composi 
mate of the conditional probability of an event (61. 
been facilitated by production of handbooks, 
and personal computer software (19). These ri 
tions devised from tbe Framingham Study dae 
shown to accurately predict disease in a variety of Ame~ca~ 
population samples (19). Unresolved issues include uncer- 
tainty as to how well these multivariate risk formulations 
derived from high incidence population samples in the 
United States apply in low incidence parts of the world, 
whether such formulations derived ecades ago app 
and how they apply in populations under treatment. 
must determine what sets of risk factor ingredient 
tute the best and most efficient risk assessment. Finally, we 
must convince physicians of the necessity and utility of such 
profiles in preventive cardiology. 
likely to be gained by getting a diabetic patient o quit 
smoking, lose weight, have blood pressure lowered and 
lipids managed and exercise more frequently than by nor- 
malizing the blood sugar. Getting a hypertensive patient o 
quit smoking confers more immediate benefit han any 
known antihypertensive drug against coronary heart disease. 
Preventive strategies must include not only preventive med- 
icine for high risk candidates but also public health measures 
to alter the ecology so as to shift the whole distribution of 
risk factors to a more favorable l vel, and health education 
to enable people to protect heir own health. In selecting 
drugs to correct hypertension, diabetes and lipid disorders, 
care must be taken to choose agents that do not adversely 
affect he composite risk profile. 
Y 
Over the four decades ofthe Framingham Study, we have 
seen a plateau in mortality from cardiovascular disease and 
then a dramatic downturn in the 1960s to the present (20). 
For the first time we are expe 
in life expectancy beyond age 
with both improvements in predisposing risk factors in the 
general population and better access to more sophisticated 
medical services (20). These remarkable decreases incoro- 
nary-, stroke-, and hypertension-related mortality are a 
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